According to Clearside Biomedical
's latest financial reports the company has $28.92 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $28.92 M | -40.07% |
2022-12-31 | $48.25 M | 58.56% |
2021-12-31 | $30.43 M | 76.06% |
2020-12-31 | $17.28 M | -23.49% |
2019-12-31 | $22.59 M | -44.73% |
2018-12-31 | $40.87 M | 8.6% |
2017-12-31 | $37.64 M | -54.99% |
2016-12-31 | $83.63 M | 312.32% |
2015-12-31 | $20.28 M | 145.29% |
2014-12-31 | $8.26 M | 333.16% |
2013-12-31 | $1.9 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 619.87% | ๐บ๐ธ USA |